Stanford Medicine researchers have created a liquid biopsy test capable of detecting cancers, molecular mechanisms of resistance to treatment and tissue injury.

Investigators from the David Geffen School of Medicine at UCLA and the UCLA Health Jonsson Comprehensive Cancer Center will be involved in more than four dozen sessions at the annual meeting of the American Urological Association April 26 to 29.

Five scientists from The University of Texas MD Anderson Cancer Center will be recognized with Scientific Achievement Awards and honors at the American Association for Cancer Research (AACR) Annual Meeting 2025.

Breakthrough research led by The University of Texas Health Science Center at San Antonio could make any IV drug able to be taken orally for a range of hard-to-treat cancers and other diseases, and redefine how medicines are designed, evaluated and delivered.

A team of researchers from the University of Chicago, in collaboration with researchers from the University of Pittsburgh, has identified a novel oncometabolite that accumulates in tumors and impairs immune cells’ ability to fight cancer.

Penn researchers will present on the latest advances in cancer science and medicine at the American Association for Cancer Research Annual Meeting.

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy, and the Johns Hopkins Convergence Institute. The study was supported in part by the National Institutes of Health, including the National Cancer Institute’s Specialized Programs of Research Excellence.